Future Care Pathways – A report from the 1st workshop of the EHC Think Tank Workstream on Future Care Pathways

1. Vanhaecht K, De Witte K, Sermeus W. The impact of clinical pathways on organisation of care pathways. PhD dissertation, 2007. Katholieke Universiteit Leuven. Available from https://lirias.kuleuven.be/1718750?limo=0 (accessed 27 June2023). Vanhaecht K De Witte K Sermeus W . The impact of clinical pathways on organisation of care pathways . PhD dissertation, 2007 . Katholieke Universiteit Leuven . Available from https://lirias.kuleuven.be/1718750?limo=0 ( accessed 27 June2023 ). Search in Google Scholar

2. European Pathway Association. About care pathways. Available from https://e-p-a.org/care-pathways (accessed 27 June 2023). European Pathway Association . About care pathways . Available from https://e-p-a.org/care-pathways ( accessed 27 June 2023 ). Search in Google Scholar

3. Letton C, Cheung C, Nordin A. Does an enhanced recovery integrated care pathway (ICP) encourage adherence to prescribing guidelines, accelerate postoperative recovery and reduce the length of stay for gynaecological oncology patients? J Obstetr Gynaecol 2013; 33: 296-297. doi: 10.3109/01443615.2012.758693. Letton C Cheung C Nordin A . Does an enhanced recovery integrated care pathway (ICP) encourage adherence to prescribing guidelines, accelerate postoperative recovery and reduce the length of stay for gynaecological oncology patients? J Obstetr Gynaecol 2013 ; 33 : 296 - 297 . doi: 10.3109/01443615.2012.758693 . Open DOISearch in Google Scholar

4. Aziz EF, Javed F, Pulimi S, et al. Implementing a pathway for the management of acute coronary syndrome leads to improved compliance with guidelines and a decrease in angina symptoms. J Healthc Qual 2012; 34: 5-14. doi: 10.1111/j.1945-1474.2011.00145.x. Aziz EF Javed F Pulimi S . Implementing a pathway for the management of acute coronary syndrome leads to improved compliance with guidelines and a decrease in angina symptoms . J Healthc Qual 2012 ; 34 : 5 - 14 . doi: 10.1111/j.1945-1474.2011.00145.x . Open DOISearch in Google Scholar

5. Deneckere S, Euwema M, Lodewijckx C, et al. Better interprofessional teamwork, higher level of organized care, and lower risk of burnout in acute health care teams using care pathways. A cluster randomized controlled trial. Med Care 2013; 51: 99-107. doi: 10.1097/MLR.0b013e3182763312. Deneckere S Euwema M Lodewijckx C . Better interprofessional teamwork, higher level of organized care, and lower risk of burnout in acute health care teams using care pathways. A cluster randomized controlled trial . Med Care 2013 ; 51 : 99 - 107 . doi: 10.1097/MLR.0b013e3182763312 . Open DOISearch in Google Scholar

6. Tremblay St-Germain A, Devitt KS, Kagedan DJ, et al. The impact of a clinical pathway on patient postoperative recovery following pancreaticoduodenectomy. HPB (Oxford) 2017; 19: 799-807. 10.1016/j.hpb.2017.04.015. Tremblay St-Germain A Devitt KS Kagedan DJ . The impact of a clinical pathway on patient postoperative recovery following pancreaticoduodenectomy . HPB (Oxford) 2017 ; 19 : 799 - 807 . 10.1016/j.hpb.2017.04.015 . Open DOISearch in Google Scholar

7. Pound CM, Gelt V, Akiki S, et al. Nurse-driven clinical pathway for inpatient asthma: a randomized controlled trial. Hospital Pediatr 2017; 7: 204–213. doi: 10.1542/hpeds.2016-0150. Pound CM Gelt V Akiki S . Nurse-driven clinical pathway for inpatient asthma: a randomized controlled trial . Hospital Pediatr 2017 ; 7 : 204 – 213 . doi: 10.1542/hpeds.2016-0150 . Open DOISearch in Google Scholar

8. Ward AJ, Murphy D, Marron R, et al. Designing rare disease care pathways in the Republic of Ireland: a co-operative model. Orphanet J Rare Dis 2022; 17: 162. doi: 10.1186/s13023-022-02309-6. Ward AJ Murphy D Marron R . Designing rare disease care pathways in the Republic of Ireland: a co-operative model . Orphanet J Rare Dis 2022 ; 17 : 162 . doi: 10.1186/s13023-022-02309-6 . Open DOISearch in Google Scholar

9. Beny K, du Sartz de Vigneulles B, Carrouel F, et al. Haemophilia in France: modelisation of the clinical pathway for patients. Int J Environ Res Public Health 2022; 19(2): 646. doi: 10.3390/ijerph19020646. Beny K du Sartz de Vigneulles B Carrouel F . Haemophilia in France: modelisation of the clinical pathway for patients . Int J Environ Res Public Health 2022 ; 19 ( 2 ): 646 . doi: 10.3390/ijerph19020646 . Open DOISearch in Google Scholar

10. Page D. Comprehensive care for hemophilia and other inherited bleeding disorders. Transfus Apher Sci 2019, 58: 565-568. doi: 10.1016/j.transci.2019.08.005. Page D . Comprehensive care for hemophilia and other inherited bleeding disorders . Transfus Apher Sci 2019 , 58 : 565 - 568 . doi: 10.1016/j.transci.2019.08.005 . Open DOISearch in Google Scholar

11. Bok A, Noone D, Skouwe-Rasmussen N; EHC Think Tank. Patient agency: key questions and challenges – A report from the 1st workshop of the EHC Think Tank Workstream on Patient Agency. J Haem Pract 2022; 9(1): 27-35. doi: 10.2478/jhp-2022-0004. Bok A Noone D Skouwe-Rasmussen N EHC Think Tank . Patient agency: key questions and challenges – A report from the 1st workshop of the EHC Think Tank Workstream on Patient Agency . J Haem Pract 2022 ; 9 ( 1 ): 27 - 35 . doi: 10.2478/jhp-2022-0004 . Open DOISearch in Google Scholar

12. Goodman M. Systems thinking: what, why, when, where and how? The Systems Thinker. Available from https://thesystemsthinker.com/systems-thinking-what-why-when-where-and-how/ (accessed 27 June 2023). Goodman M . Systems thinking: what, why, when, where and how? The Systems Thinker . Available from https://thesystemsthinker.com/systems-thinking-what-why-when-where-and-how/ ( accessed 27 June 2023 ). Search in Google Scholar

13. Gittus M, Chong J, Sutton A, Ong ACM, Fotheringham J. Barriers and facilitators to the implementation of guidelines in rare diseases: a systematic review. Orphanet J Rare Dis 2023; 18: 140. doi: 10.1186/s13023-023-02667-9. Gittus M Chong J Sutton A Ong ACM Fotheringham J . Barriers and facilitators to the implementation of guidelines in rare diseases: a systematic review . Orphanet J Rare Dis 2023 ; 18 : 140 . doi: 10.1186/s13023-023-02667-9 . Open DOISearch in Google Scholar

14. Rand L, Dunn M, Slade I, et al. Understanding and using patient experiences as evidence in healthcare priority setting. Cost Eff Resour Alloc 2019; 17: 20. doi: 10.1186/s12962-019-0188-1. Rand L Dunn M Slade I . Understanding and using patient experiences as evidence in healthcare priority setting . Cost Eff Resour Alloc 2019 ; 17 : 20 . doi: 10.1186/s12962-019-0188-1 . Open DOISearch in Google Scholar

15. Facey KM, Rannanheimo P, Batchelor L, Borchardt M, de Cock J. Real-world evidence to support payer/HTA decisions about highly innovative technologies in the EU – actions for stakeholders. Int J Technol Assess Health Care 202; 36: 459-468. doi: 10.1017/S026646232000063X. Facey KM Rannanheimo P Batchelor L Borchardt M de Cock J . Real-world evidence to support payer/HTA decisions about highly innovative technologies in the EU – actions for stakeholders . Int J Technol Assess Health Care 202; 36 : 459 - 468 . doi: 10.1017/S026646232000063X . Open DOISearch in Google Scholar

16. Zhou Z-Y, Koerper MA, Johnson KA, et al. Burden of illness: direct and indirect costs among persons with hemophilia A in the United States. J Med Econ 2015; 18:6, 457-465. doi: 10.3111/13696998.2015.1016228. Zhou Z-Y Koerper MA Johnson KA . Burden of illness: direct and indirect costs among persons with hemophilia A in the United States . J Med Econ 2015 ; 18 : 6 , 457 - 465 . doi: 10.3111/13696998.2015.1016228 . Open DOISearch in Google Scholar

17. Pearson I, Rothwell B, Olaye A, Knight C. Economic modeling considerations for rare diseases. Value in Health 2018; 21(5): 515-524. doi: 10.1016/j.jval.2018.02.008. Pearson I Rothwell B Olaye A Knight C . Economic modeling considerations for rare diseases . Value in Health 2018 ; 21 ( 5 ): 515 - 524 . doi: 10.1016/j.jval.2018.02.008 . Open DOISearch in Google Scholar

18. Garrison LP Jr, Jiao B, Dabbous O. Gene therapy may not be as expensive as people think: challenges in assessing the value of single and short-term therapies. J Manag Care Spec Pharm 2021; 27(5): 674-681. doi: 10.18553/jmcp.2021.27.5.674. Garrison LP Jr Jiao B Dabbous O . Gene therapy may not be as expensive as people think: challenges in assessing the value of single and short-term therapies . J Manag Care Spec Pharm 2021 ; 27 ( 5 ): 674 - 681 . doi: 10.18553/jmcp.2021.27.5.674 . Open DOISearch in Google Scholar

19. Goodman C, Berntorp E, Wong O, the International Haemophilia Access Strategy Council. Alternative payment models for durable and potentially curative therapies: The case of gene therapy for haemophilia A. Haemophilia 2022; 28(S2): 27-34. doi: 10.1111/hae.14425. Goodman C Berntorp E Wong O the International Haemophilia Access Strategy Council . Alternative payment models for durable and potentially curative therapies: The case of gene therapy for haemophilia A . Haemophilia 2022 ; 28 (S2): 27 - 34 . doi: 10.1111/hae.14425 . Open DOISearch in Google Scholar

20. Bolz-Johnson M, Kenny T, Le Cam Y, Hernando I. Our greatest untapped resource: our patients. J Community Genet 2021; 12: 241-246. doi: 10.1007/s12687-021-00524-5. Bolz-Johnson M Kenny T Le Cam Y Hernando I . Our greatest untapped resource: our patients . J Community Genet 2021 ; 12 : 241 - 246 . doi: 10.1007/s12687-021-00524-5 . Open DOISearch in Google Scholar

21. Wind A, van der Linden C, Hartman E, et al. Patient involvement in clinical pathway development, implementation and evaluation – A scoping review of international literature. Patient Educ Couns 2022; 105 (6) 1441-1448. doi: 10.1016/j.pec.2021.10.007. Wind A van der Linden C Hartman E . Patient involvement in clinical pathway development, implementation and evaluation – A scoping review of international literature . Patient Educ Couns 2022 ; 105 ( 6 ) 1441 - 1448 . doi: 10.1016/j.pec.2021.10.007 . Open DOISearch in Google Scholar

22. Colvin BT, Astermark J, Fischer K, et al., for the Inter Disciplinary Working Group. European principles of haemophilia care. Haemophilia 2008; 14(2): 361-374. doi: 10.1111/j.1365-2516.2007.01625.x. Colvin BT Astermark J Fischer K for the Inter Disciplinary Working Group . European principles of haemophilia care . Haemophilia 2008 ; 14 ( 2 ): 361 - 374 . doi: 10.1111/j.1365-2516.2007.01625.x . Open DOISearch in Google Scholar

23. Khayatzadeh-Mahani A, Nolte E, Sutherland J, Forest P-G. International experiments with different models of allocating funds to facilitate integrated care: a scoping review protocol. BMJ Open 2018; 8(11): e021374. doi: 10.1136/bmjopen-2017-021374. Khayatzadeh-Mahani A Nolte E Sutherland J Forest P-G . International experiments with different models of allocating funds to facilitate integrated care: a scoping review protocol . BMJ Open 2018 ; 8 ( 11 ): e021374 . doi: 10.1136/bmjopen-2017-021374 . Open DOISearch in Google Scholar

24. Rosell L, Alexandersson N, Hagberg O, Nilbert M. Benefits, barriers and opinions on multidisciplinary team meetings: a survey in Swedish cancer care. BMC Health Serv Res 2018; 18: 249. doi: 10.1186/s12913-018-2990-4. Rosell L Alexandersson N Hagberg O Nilbert M . Benefits, barriers and opinions on multidisciplinary team meetings: a survey in Swedish cancer care . BMC Health Serv Res 2018 ; 18 : 249 . doi: 10.1186/s12913-018-2990-4 . Open DOISearch in Google Scholar

25. Simpson A, Bloom L, Fulop NJ, et al. How are patients with rare diseases and their carers in the UK impacts by the way care is coordinated? An exploratory qualitative interview study. Orphanet J Rare Dis 2021; 16: 76. doi: 10.1186/s13023-020-01664-6. Simpson A Bloom L Fulop NJ . How are patients with rare diseases and their carers in the UK impacts by the way care is coordinated? An exploratory qualitative interview study . Orphanet J Rare Dis 2021 ; 16 : 76 . doi: 10.1186/s13023-020-01664-6 . Open DOISearch in Google Scholar

26. Tumiene B, Graessner H. Rare disease care pathways in the EU: from odysseys and labyrinths towards highways. J Community Genet 2021; 12(2): 231-239. doi: 10.1007/s12687-021-00520-0. Tumiene B Graessner H . Rare disease care pathways in the EU: from odysseys and labyrinths towards highways . J Community Genet 2021 ; 12 ( 2 ): 231 - 239 . doi: 10.1007/s12687-021-00520-0 . Open DOISearch in Google Scholar

27. Colvin BT, Astermark J, Fischer K, et al., for the Inter Disciplinary Working Group. European principles of haemophilia care. Haemophilia 2008; 14(2): 361-374. doi: 10.1111/j.1365-2516.2007.01625.x. Colvin BT Astermark J Fischer K for the Inter Disciplinary Working Group . European principles of haemophilia care . Haemophilia 2008 ; 14 ( 2 ): 361 - 374 . doi: 10.1111/j.1365-2516.2007.01625.x . Open DOISearch in Google Scholar

28. van Balen EC, O’Mahony B, Cnossen MH, et al. Patient-relevant health outcomes for hemophilia care: Development of an international standard outcomes set. Res Pract Thromb Haemost 2021; 6(5): e12488. doi: 10.1002/rth2.12488. van Balen EC O’Mahony B Cnossen MH . Patientrelevant health outcomes for hemophilia care: Development of an international standard outcomes set . Res Pract Thromb Haemost 2021 ; 6 ( 5 ): e12488 . doi: 10.1002/rth2.12488 . Open DOISearch in Google Scholar

29. Kole A, Faurisson F. Rare diseases social epidemiology: analysis of inequalities. In: Posada de la Paz M, Groft S (eds). Rare Diseases Epidemiology. Advances in Experimental Medicine and Biology vol. 686. Dordrecht: Springer, 2010. doi: 10.1007/978-90-481-9485-8_14. Kole A Faurisson F . Rare diseases social epidemiology: analysis of inequalities . In: Posada de la Paz M Groft S (eds). Rare Diseases Epidemiology. Advances in Experimental Medicine and Biology vol. 686 . Dordrecht : Springer , 2010 . doi: 10.1007/978-90-481-9485-8_14 . Open DOISearch in Google Scholar

30. Weyand AC, James PD. Sexism in the management of bleeding disorders. Res Pract Thromb Haemost 2020; 5(1): 51-54. doi: 10.1002/rth2.12468. Weyand AC James PD . Sexism in the management of bleeding disorders . Res Pract Thromb Haemost 2020 ; 5 ( 1 ): 51 - 54 . doi: 10.1002/rth2.12468 . Open DOISearch in Google Scholar

31. Di Michele DM, Gibb C, Lefkowitz JM, et al. Severe and moderate haemophilia A and B in US females. Haemophilia 2014; 20(2): e136-143. doi: 10.1111/hae.12364. Di Michele DM Gibb C Lefkowitz JM . Severe and moderate haemophilia A and B in US females . Haemophilia 2014 ; 20 ( 2 ): e136 - 143 . doi: 10.1111/hae.12364 . Open DOISearch in Google Scholar

32. EURORDIS. Solve-RD infographic on the patient journey to diagnosis. July 2020. Available from https://www.eurordis.org/publications/solve-rd-infographic-on-the-patient-journey-to-diagnosis/ (accessed 19 July 2023). EURORDIS . Solve-RD infographic on the patient journey to diagnosis . July 2020 . Available from https://www.eurordis.org/publications/solve-rd-infographic-on-the-patient-journey-to-diagnosis/ ( accessed 19 July 2023 ). Search in Google Scholar

33. Thorat T, Neumann PJ, Chambers JD. Hemophilia burden of disease: a systematic review of the cost-utility literature for hemophilia. J Manag Care Spec Pharm 2018; 24(7): 632-642. doi: 10.18553/jmcp.2018.24.7.632. Thorat T Neumann PJ Chambers JD . Hemophilia burden of disease: a systematic review of the cost-utility literature for hemophilia . J Manag Care Spec Pharm 2018 ; 24 ( 7 ): 632 - 642 . doi: 10.18553/jmcp.2018.24.7.632 . Open DOISearch in Google Scholar

34. Pagès-Puigdemont N, Mangues MA, Masip M, et al. Patients’ perspectives of medication adherence in chronic conditions: a qualitative study. Adv Ther 2016; 33: 1740-1754. doi: 10.1007/s12325-016-0394-6. Pagès-Puigdemont N Mangues MA Masip M . Patients’ perspectives of medication adherence in chronic conditions: a qualitative study . Adv Ther 2016 ; 33 : 1740 - 1754 . doi: 10.1007/s12325-016-0394-6 . Open DOISearch in Google Scholar

35. Zimlichman E, Nicklin W, Aggarwal R, Bates DW. Health care 2030: the coming transformation. NEJM Catalyst 2021, March 3. doi: 10,.1056/CAT.20.0569. Zimlichman E Nicklin W Aggarwal R Bates DW . Health care 2030: the coming transformation . NEJM Catalyst 2021 , March 3 . doi: 10,.1056/CAT.20.0569 . Open DOISearch in Google Scholar

36. European Commission Directorate-General for Food and Health Safety. Proposal for a Regulation – The European Health Data Space. COM(2022) 197/2. 3 May 2022. Available from https://health.ec.europa.eu/publications/proposal-regulation-european-health-data-space_en (accessed 12 July 2023). European Commission Directorate-General for Food and Health Safety . Proposal for a Regulation – The European Health Data Space . COM(2022) 197/2 . 3 May 2022 . Available from https://health.ec.europa.eu/publications/proposal-regulation-european-health-data-space_en ( accessed 12 July 2023 ). Search in Google Scholar

37. European Commission. Proposal for a Regulation of the European Parliament and of the Council Laying Down Harmonised Rules on Artificial Intelligence (Artificial Intelligence Act) and Amending Certain Union Legislative Acts. 2021/0106 (COD). 21 April 2021. Available from https://artifícialintelligenceact.eu/the-act/ (accessed 12 July 2023). European Commission . Proposal for a Regulation of the European Parliament and of the Council Laying Down Harmonised Rules on Artificial Intelligence (Artificial Intelligence Act) and Amending Certain Union Legislative Acts . 2021/0106 (COD). 21 April 2021 . Available from https://artifícialintelligenceact.eu/the-act/ ( accessed 12 July 2023 ). Search in Google Scholar

38. Mittelstadt BD, Floridi L. The ethics of big data: current and foreseeable issues in biomedical contexts. Sci Eng Ethics 2016; 22(2): 303-41. doi: 10.1007/s11948-015-9652-2. Mittelstadt BD Floridi L . The ethics of big data: current and foreseeable issues in biomedical contexts . Sci Eng Ethics 2016 ; 22 ( 2 ): 303 - 41 . doi: 10.1007/s11948-015-9652-2 . Open DOISearch in Google Scholar

39. Petracca F, Tempre R, Cucciniello M, et al. An electronic patient-reported outcome mobile app for data collection in type a hemophilia: design and usability study. JMIR Form Res 2021; 5(12): e25071. doi: 10.2196/25071. Petracca F Tempre R Cucciniello M . An electronic patient-reported outcome mobile app for data collection in type a hemophilia: design and usability study . JMIR Form Res 2021 ; 5 ( 12 ): e25071 . doi: 10.2196/25071 . Open DOISearch in Google Scholar

40. Donald A, Cizer H, Finnegan N, et al. Measuring disease activity and patient experience remotely using wearable technology and a mobile phone app: outcomes from a pilot study in Gaucher disease. Orphanet J Rare Dis 2019; 14(1): 212. doi: 10.1186/s13023-019-1182-6. Donald A Cizer H Finnegan N . Measuring disease activity and patient experience remotely using wearable technology and a mobile phone app: outcomes from a pilot study in Gaucher disease . Orphanet J Rare Dis 2019 ; 14 ( 1 ): 212 . doi: 10.1186/s13023-019-1182-6 . Open DOISearch in Google Scholar

41. Lehne M, Sass J, Essenwanger A, Schepers J, Thun S. Why digital medicine depends on interoperability. NPJ Digit Med 2019; 2: 79. doi: 10.1038/s41746-019-0158-1. Lehne M Sass J Essenwanger A Schepers J Thun S . Why digital medicine depends on interoperability . NPJ Digit Med 2019 ; 2 : 79 . doi: 10.1038/s41746-019-0158-1 . Open DOISearch in Google Scholar

42. Gomes M, Murray E, Rafery J. Economic evaluation of digital health interventions: methodological issues and recommendations for practice. Pharmacoeconomics 2022; 40(4): 367-378. doi: 10.1007/s40273-022-01130-0. Gomes M Murray E Rafery J . Economic evaluation of digital health interventions: methodological issues and recommendations for practice . Pharmacoeconomics 2022 ; 40 ( 4 ): 367 - 378 . doi: 10.1007/s40273-022-01130-0 . Open DOISearch in Google Scholar

43. Alami H, Gagnon M-P, Fortin J-P. Digital health and the challenge of health systems transformation. Mhealth 2017; 3: 31. doi: 10.21037/mhealth.2017.07.02. Alami H Gagnon M-P Fortin J-P . Digital health and the challenge of health systems transformation . Mhealth 2017 ; 3 : 31 . doi: 10.21037/mhealth.2017.07.02 . Open DOISearch in Google Scholar

44. Castro R, de Chalendar M, Vajda I, et al. Rare diseases. In: Amelung V, Stein V, Suter E, et al. (eds). Handbook Integrated Care. 2020. Springer, Cham. doi: 10.1007/978-3-030-69262-9_44. Castro R de Chalendar M Vajda I . Rare diseases . In: Amelung V Stein V Suter E . (eds). Handbook Integrated Care . 2020 . Springer , Cham . doi: 10.1007/978-3-030-69262-9_44 . Open DOISearch in Google Scholar

45. van Galen K, Lavin M, Skouw-Rasmussen N, et al. European principles of care for women and girls with inherited bleeding disorders. Haemophilia 2021; 27(5): 837-847. doi: 10.1111/hae.14379. van Galen K Lavin M Skouw-Rasmussen N . European principles of care for women and girls with inherited bleeding disorders . Haemophilia 2021 ; 27 ( 5 ): 837 - 847 . doi: 10.1111/hae.14379 . Open DOISearch in Google Scholar

46. Halley MC, Halverson CME, Tabor HK, Goldenberg AJ. Rare disease, advocacy and justice: intersecting disparities in research and clinical care. Am J Bioethics 2023; 7: 17-26. doi: 10.1080/15265161.2023.2207500. Halley MC Halverson CME Tabor HK Goldenberg AJ . Rare disease, advocacy and justice: intersecting disparities in research and clinical care . Am J Bioethics 2023 ; 7 : 17 - 26 . doi: 10.1080/15265161.2023.2207500 . Open DOISearch in Google Scholar

47. De Santis M, Hervas C, Weinman A, Bosi G, Bottarelli V. Patient empowerment of people living with rare diseases. Its contribution to sustainable and resilient healthcare systems. Ann Ist Super Sanit 2019; 55(3): 283-291. doi: 10.4415/ANN_19_03_15. De Santis M Hervas C Weinman A Bosi G Bottarelli V . Patient empowerment of people living with rare diseases. Its contribution to sustainable and resilient healthcare systems . Ann Ist Super Sanit 2019 ; 55 ( 3 ): 283 - 291 . doi: 10.4415/ANN_19_03_15 . Open DOISearch in Google Scholar

48. Leanza Y, Boivin I, Rosenberg E. Interruptions and resistance: A comparison of medical consultations with family and trained interpreters. Soc Sci Med 2010; 70(12): 1888-1895. doi: 10.1016/j.socscimed.2010.02.036. Leanza Y Boivin I Rosenberg E . Interruptions and resistance: A comparison of medical consultations with family and trained interpreters . Soc Sci Med 2010 ; 70 ( 12 ): 1888 - 1895 . doi: 10.1016/j.socscimed.2010.02.036 . Open DOISearch in Google Scholar

49. EHC. Think Tank. Available from https://ehcthinktank.eu (accessed 19 July 2023). EHC . Think Tank . Available from https://ehcthinktank.eu ( accessed 19 July 2023 ). Search in Google Scholar

50. Chatham House. Chatham House rule. Available from https://www.chathamhouse.org/about-us/chatham-house-rule (accessed 19 July 2023). Chatham House . Chatham House rule . Available from https://www.chathamhouse.org/about-us/chatham-house-rule ( accessed 19 July 2023 ). Search in Google Scholar